The global Montelukast Sodium Market is witnessing accelerated growth as healthcare providers increasingly prioritize long-term respiratory disease management and patient-centered treatment approaches. The market was valued at USD 293.80 million in 2023 and is projected to reach USD 773.78 million by 2032, growing at a CAGR of 11.4% from 2024 to 2032. Rising incidences of asthma, allergic...